Treatment Biden is restricting for Covid reduces hospitalization and death risk

 UPI:

Treatment with monoclonal antibodies reduced the need for hospital care in adults at high risk for serious illness from COVID-19, a study published Tuesday by JAMA Network Open found.

Just over 17% of high-risk Native Americans given the treatment based on laboratory-created antibodies, or immune proteins that fight off infections, within days of testing positive for the virus were admitted to the hospital, the data showed.

However, 43% of patients in the study who did not receive monoclonal antibodies required hospital treatment.

In addition, more than 4% of the untreated patients were admitted to a hospital intensive care unit because of COVID-19, and nearly 3% died from the disease.

None of the patients given monoclonal antibodies were admitted to the ICU and none died, they said.
...

This is a treatment that was in wide use in the Red States until Biden decided to ration it leading some states to not allow it for patients who were fully vaccinated.  Others will go untreated because of Biden's arbitrary restrictions. 

Comments

Popular posts from this blog

Should Republicans go ahead and add Supreme Court Justices to head off Democrats

Is the F-35 obsolete?

Apple's huge investment in US including Texas facility